Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Zhiyu Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-4316-0952; OpenAlex author ID A5115588715. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 4

  1. Transcriptome Landscape of Cancer-Associated Fibroblasts in Human PDAC. Co-author DOI 10.1002/advs.202415196↗
  2. A commentary on 'The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. A cross sectional study' - a correspondence. Last author DOI 10.1097/js9.0000000000000680↗
  3. PUM1 is upregulated by DNA methylation to suppress antitumor immunity and results in poor prognosis in pancreatic cancer. Last author DOI 10.21037/tcr-20-3295↗
  4. Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway. Last author DOI 10.2147/ott.s284219↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xue‐Lei Li · 1 shared paper, 2023 · strength 0.24
  2. Xingxing Su · 2 shared papers, 2020–2021 · strength 0.22
  3. Yishi Yang · 2 shared papers, 2020–2021 · strength 0.22
  4. Haisu Dai · 2 shared papers, 2020–2021 · strength 0.22
  5. Mengyu Tao · 1 shared paper, 2025 · strength 0.21
  6. Hongxia Wang · 1 shared paper, 2025 · strength 0.21
  7. Yan Jiang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.